FOXC2 and cancer: FOXC2 has been proposed as a potential therapeutic target because it is involved in multiple processes that support cancer growth, metastasis, and chemotherapy resistance, such as EMT, CSC differentiation, angiogenesis, and resistance to anoikis [36,62,85,86].